Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;22(2):88-101.
doi: 10.1111/cns.12486. Epub 2015 Dec 10.

Preclinical Assessment of Inflammatory Pain

Milind M Muley  1 , Eugene Krustev  1 , Jason J McDougall  1
Affiliations
Review

Preclinical Assessment of Inflammatory Pain

Milind M Muley et al. CNS Neurosci Ther. 2016 Feb.

Abstract

While acute inflammation is a natural physiological response to tissue injury or infection, chronic inflammation is maladaptive and engenders a considerable amount of adverse pain. The chemical mediators responsible for tissue inflammation act on nociceptive nerve endings to lower neuronal excitation threshold and sensitize afferent firing rate leading to the development of allodynia and hyperalgesia, respectively. Animal models have aided in our understanding of the pathophysiological mechanisms responsible for the generation of chronic inflammatory pain and allowed us to identify and validate numerous analgesic drug candidates. Here we review some of the commonly used models of skin, joint, and gut inflammatory pain along with their relative benefits and limitations. In addition, we describe and discuss several behavioral and electrophysiological approaches used to assess the inflammatory pain in these preclinical models. Despite significant advances having been made in this area, a gap still exists between fundamental research and the implementation of these findings into a clinical setting. As such we need to characterize inherent pathophysiological pathways and develop new endpoints in these animal models to improve their predictive value of human inflammatory diseases in order to design safer and more effective analgesics.

Keywords: Animal models; Arthritis; Behavior; Cutaneous pain; Inflammation; Laboratory assessment; Nociception; Visceral pain.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A schematic illustrating peripheral sensitization of a free nerve ending by various inflammatory mediators and irritant substances. Capsaicin, mustard oil, acid, and formalin increase the sensitivity of neurones by opening transient receptor potential vanilloid type 1 (TRPV1) ion channels, which leads to the release of neuropeptides such as substance P (SP) and vasoactive intestinal peptide (VIP). Locally released SP binds to neurokinin 1 (NK1) receptors and VIP binds to VPAC1 receptors. Histamine released from mast cells acts on neuronal H1 receptors. Leukocytes and mast cell release serine proteases which subsequently cleave various proteinase‐activated receptors (PAR) leading to downstream nociceptor modulation. Toll‐like receptor 4 (TLR4) is activated by exogenous substances like carrageenan and lipopolysaccharides (LPS), while leukocyte‐derived cytokines like tumor necrosis factor‐α (TNF‐α), interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and interleukin‐17 (IL‐17) bind to their respective receptors to enhance pain transmission. Prostaglandin E2 (PGE 2) mainly activates the PGE 2 receptor and sensitizes sensory neurones to environmental stimuli.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth 2001;87:3–11. - PubMed
    1. Lipnik‐Stangelj M. Mediators of inflammation as targets for chronic pain treatment. Mediators Inflamm 2013;2013:783235. - PMC - PubMed
    1. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy 2014;69:3–16. - PubMed
    1. Widdifield J, Paterson JM, Bernatsky S, et al. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheumatol 2014;66:786–793. - PubMed
    1. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:1–20. - PubMed

Substances